Skip to main content

Advertisement

Log in

Reply to: "Impact of Primary-Site Local Therapy in Patients with De Novo Metastatic Breast Cancer," by Makris, Eleftherios et al.

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Khan SA, Schuetz S, Hosseini O. Primary-site local therapy for patients with de novo metastatic breast cancer: an educational review. Ann Surg Oncol. 2022;29:5811–20.

    Article  Google Scholar 

  2. Soran A, Ozmen V, Ozbas S, et al. Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: Protocol MF07-01. Ann Surg Oncol. 2018;25:3141–9.

    Article  Google Scholar 

  3. Khan SA, Zhao F, Goldstein LJ, et al. Early local therapy for the primary site in de novo stage IV breast cancer: results of a randomized clinical trial (EA2108). J Clin Oncol. 2022;2102006.

  4. Soran A, Aytac O, Ozbas S. Locoregional therapy for intact primary tumor in de novo stage IV breast cancer. J Clin Oncol. 2022;2200802.

  5. Khan SA, Zhao F, Goldstein L, et al. Reply to B. Ulas Kahya et al and A. Soran et al. J Clin Oncol. 2022;2200861.

  6. Wang J, Tang H, Yin K, et al. Second invasive breast cancers in patients treated with breast-conserving therapy. Eur J Surg Oncol. 2021;47:2492–8.

    Article  Google Scholar 

  7. Abraha I, Montedori A. Modified intention to treat reporting in randomised controlled trials: systematic review. BMJ. 2010;340:c2697.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Seema Ahsan Khan MD.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khan, S.A., Schuetz, S. & Hosseini, O. Reply to: "Impact of Primary-Site Local Therapy in Patients with De Novo Metastatic Breast Cancer," by Makris, Eleftherios et al.. Ann Surg Oncol 30, 1072–1073 (2023). https://doi.org/10.1245/s10434-022-12873-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12873-7

Navigation